Cell and Gene Outsourcing

  1. Defining Quality In A Sponsor-Owned QTPP Before The CDMO Even Starts 7/29/2026

    Version-controlled quality target product profiles, authored by the drug sponsor, close any gaps between the CDMO's and sponsor's definitions of quality.

  2. From Cell Bank To Clinic Faster: GMP Manufacturing & Characterization 7/28/2026

    Accelerate your path to the clinic with an integrated, risk-based cell banking strategy that delivers speed, quality, and regulatory confidence at every stage.

  3. Pharma Procurement Playbook: A Guide To Supplier Selection 7/27/2026

    Stop optimizing supplier selection for cost alone. This playbook from Collaborative Sourcing's Matthew Holt and Graham Phillipson gives pharma executives a cross-functional framework for selecting CDMOs and API manufacturers that won't fail you later.

  4. The CDMO Pricing Playbook 7/27/2026

    Why do two CDMOs with identical direct costs quote prices 2.6x apart? Learn the three-element pricing framework, capacity utilization math, and market-based strategies that explain every RFQ surprise.

  5. Reshoring Pressure Meets Manufacturing Reality 7/27/2026

    U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.

  6. Target Product Profile (TPP) Explained 7/27/2026

    Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.

  7. Drug Development Readiness: Interactive Checklist And RACI 7/27/2026

    Early decisions can have long-lasting consequences for development timelines, cost, risk, and overall probability of success. Engaging the appropriate disciplines early helps avoid downstream surprises and rework.

  8. CDMO Live Europe 2026: Partnerships For An Uncertain World 7/27/2026

    112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.

  9. Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report 7/27/2026

    Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.

  10. The Hidden Cost of CRO Change Orders and How Sponsors Can Best Manage Them 7/24/2026

    Improve budget oversight, forecast costs more accurately, and maintain a clear audit trail to minimize surprises and streamline CRO change orders.